TSS
ZVRA icon

Two Sigma Securities’s Zevra Therapeutics ZVRA Stock Holding History

Two Sigma Securities’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$198K Buy
+13,834
New +$154K 0.02% 1179
2019
Q2 		– Sell
-704
Closed -$19K – 2482
2019
Q1 		$19K Buy
+704
New +$25.9K ﹤0.01% 1676

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Securities's ZVRA Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Zevra Therapeutics (ZVRA) in Q2 2026: 13,834 shares worth $198K. The stake represents 0.02% of the portfolio and ranks #1179 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ZVRA as recently as Q1 2019.

Two Sigma Securities first reported a position in ZVRA in Q1 2019 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Two Sigma Securities held 13,834 shares of Zevra Therapeutics worth $198K as of Q2 2026.
  • Zevra Therapeutics was a new Two Sigma Securities position in Q2 2026.
  • Zevra Therapeutics made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #1179 holding.
  • Two Sigma Securities first reported a position in Zevra Therapeutics in Q1 2019 and has held it in 2 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.